Cargando…

Impact of non-uniform attenuation correction in a dynamic [(18)F]-FDOPA brain PET/MRI study

BACKGROUND: PET (positron emission tomography) biokinetic modelling relies on accurate quantitative data. One of the main corrections required in PET imaging to obtain high quantitative accuracy is tissue attenuation correction (AC). Incorrect non-uniform PET-AC may result in local bias in the emiss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabello, Jorge, Avram, Mihai, Brandl, Felix, Mustafa, Mona, Scherr, Martin, Leucht, Claudia, Leucht, Stefan, Sorg, Christian, Ziegler, Sibylle I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702490/ https://www.ncbi.nlm.nih.gov/pubmed/31428975 http://dx.doi.org/10.1186/s13550-019-0547-0

Ejemplares similares

S145. CORTICO-THALAMIC DYSCONNECTIVITY LINKS WITH ABERRANT STRIATAL DOPAMINE IN SCHIZOPHRENIA A SIMULTANEOUS 18F-DOPA-PET/RESTING-STATE FMRI STUDY
por: Avram, Mihai, et al.
Publicado: (2020)

S146. ASSOCIATION OF IMPAIRED MODEL-FREE DECISION-MAKING WITH ABERRANT STRIATAL DOPAMINE, BRAIN ACTIVATION, AND COGNITIVE DIFFICULTIES IN PATIENTS WITH SCHIZOPHRENIA DURING PSYCHOTIC REMISSION
por: Brandl, Felix, et al.
Publicado: (2020)

Lower cholinergic basal forebrain volumes link with cognitive difficulties in schizophrenia
por: Avram, Mihai, et al.
Publicado: (2021)

Accurate detection of intracranial extension of jugulotympanic paraganglioma by [(18)F]FDOPA-PET/CT comparing to MRI
por: Araghi, Zahra Jamshidi, et al.
Publicado: (2021)

(18)F-FDOPA PET/CT Combined with MRI for Gross Tumor Volume Delineation in Patients with Skull Base Paraganglioma
por: Helali, Mehdi, et al.
Publicado: (2019)

Adrenal tracer uptake by (18)F-FDOPA PET/CT in patients with pheochromocytoma and controls
por: Noordzij, Walter, et al.
Publicado: (2019)

Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders
por: Stormezand, Gilles N., et al.
Publicado: (2020)

(18)F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma
por: Tepede, Aisha A, et al.
Publicado: (2020)

Comparison of 6-[(18)F]FDOPA PET with Nigrosome 1 detection in patients with parkinsonism
por: Michler, Enrico, et al.
Publicado: (2021)

Pharmacokinetic Modeling of (18)F-FDOPA PET in the Human Brain for Early Parkinson’s Disease
por: Buratachwatanasiri, Wirunpatch, et al.
Publicado: (2021)

MLTI-18. PRECISION IMAGING OF METASTATIC AND PRIMARY BRAIN TUMORS AFTER RADIATION WITH (18)F-FDOPA PET-MRI IS FEASIBLE AND COST EFFECT
por: Aboian, Mariam, et al.
Publicado: (2019)

The impact of 18F-FDOPA-PET/MRI image fusion in detecting liver metastasis in patients with neuroendocrine tumors of the gastrointestinal tract
por: Barachini, O., et al.
Publicado: (2020)

Effects of Carbidopa Premedication on (18)F-FDOPA PET Imaging of Glioma: A Multiparametric Analysis
por: Bros, Marie, et al.
Publicado: (2021)

The Role of (18)F-FDOPA PET/CT in Recurrent Medullary Thyroid Cancer Patients with Elevated Serum Calcitonin Levels
por: Araz, Mine, et al.
Publicado: (2023)

Comparative evaluation of 18F-FDOPA, 13N-AMMONIA, 18F-FDG PET/CT and MRI in primary brain tumors - A pilot study
por: Jora, Charu, et al.
Publicado: (2011)

An automatic analysis framework for FDOPA PET neuroimaging
por: Nordio, Giovanna, et al.
Publicado: (2023)

Usefulness of (18)F-FDOPA PET for the management of primary brain tumors: a systematic review of the literature
por: Somme, François, et al.
Publicado: (2020)

Dynamic (18)F-FDopa PET Imaging for Newly Diagnosed Gliomas: Is a Semiquantitative Model Sufficient?
por: Zaragori, Timothée, et al.
Publicado: (2021)

A potential biomarker for treatment stratification in psychosis: evaluation of an [(18)F] FDOPA PET imaging approach
por: Veronese, Mattia, et al.
Publicado: (2020)

Development and validation of a radiomic model for the diagnosis of dopaminergic denervation on [18F]FDOPA PET/CT
por: Comte, Victor, et al.
Publicado: (2022)

Diagnostic and grading accuracy of (18)F-FDOPA PET and PET/CT in patients with gliomas: a systematic review and meta-analysis
por: Xiao, Jiarui, et al.
Publicado: (2019)

Use of [(18)F]FDOPA-PET for in vivo evaluation of dopaminergic dysfunction in unilaterally 6-OHDA-lesioned rats
por: Kyono, Kiyoshi, et al.
Publicado: (2011)

18F-FDOPA PET/CT SUV-Derived Indices and Volumetric Parameters Correlation in Patients with Primary Brain Tumors
por: Chiaravalloti, Agostino, et al.
Publicado: (2021)

Additive Value of Dynamic FDOPA PET/CT for Glioma Grading
por: Girard, Antoine, et al.
Publicado: (2021)

The effects of molar activity on [(18)F]FDOPA uptake in patients with neuroendocrine tumors
por: Stormezand, Gilles N., et al.
Publicado: (2021)

SAT-310 (18)F-FDOPA PET/CT Accurately Identifies Pheochromocytoma in 70-Year-Old Male with MEN1
por: Tepede, Aisha, et al.
Publicado: (2019)

MR-based attenuation correction in brain PET based on UTE sequences
por: Cabello, Jorge, et al.
Publicado: (2014)

Nucleophilic Synthesis of 6-l-[(18)F]FDOPA. Is Copper-Mediated Radiofluorination the Answer?
por: Krasikova, Raisa N.
Publicado: (2020)

Striatal dopamine synthesis capacity in autism spectrum disorder and its relation with social defeat: an [(18)F]-FDOPA PET/CT study
por: Schalbroeck, Rik, et al.
Publicado: (2021)

Early acquisition of [(18)F]FDOPA PET/CT imaging in patients with recurrent or residual medullary thyroid cancer is safe—and slightly better!
por: Kjærulff, Mette Louise Gram, et al.
Publicado: (2022)

Cerebral [(18)F]-FDOPA Uptake in Autism Spectrum Disorder and Its Association with Autistic Traits
por: Schalbroeck, Rik, et al.
Publicado: (2021)

Correlation between (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in patients with Parkinson’s disease: a pilot study
por: Arena, Julieta E., et al.
Publicado: (2021)

Evaluation of Intraperitoneal [(18)F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity
por: Halff, Els F., et al.
Publicado: (2022)

Implementing the Point Spread Function Deconvolution for Better Molecular Characterization of Newly Diagnosed Gliomas: A Dynamic (18)F-FDOPA PET Radiomics Study
por: Ahrari, Shamimeh, et al.
Publicado: (2022)

Enzyme inhibition of dopamine metabolism alters 6-[(18)F]FDOPA uptake in orthotopic pancreatic adenocarcinoma
por: Tuomela, Johanna, et al.
Publicado: (2013)

[18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression
por: Dadone-Montaudié, Bérengère, et al.
Publicado: (2017)

Automated Data Quality Control in FDOPA brain PET Imaging using Deep Learning
por: Pontoriero, Antonella D., et al.
Publicado: (2021)

Impact of attenuation correction on clinical [(18)F]FDG brain PET in combined PET/MRI
por: Werner, P., et al.
Publicado: (2016)

Clinical impact of dual-tracer FDOPA and FDG PET/CT for the evaluation of patients with parkinsonian syndromes
por: Emsen, Berivan, et al.
Publicado: (2020)

SUN-116 The Role of (68)Gallium DOTATATE PET/CT Versus (18)F-FDOPA PET/CT in the Imaging of Neuroendocrine Neoplasms in Patients with Multiple Endocrine Neoplasia Type 1 (MEN1)
por: Tepede, Aisha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nd3ttbg1mii3hetepiujbo3a6h